SCHEMBL7712468

SCHEMBL7712468

OCCN1CCN(c2nc(N3CCCCC3)ncc2Oc2ccc(Cl)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
KMT2A Q03164 1/20 0.51
ROCK2 O75116 1/20 0.43
ROCK1 Q13464 1/20 0.43
LMNA P02545 1/20 0.43
LTA4H P09960 1/20 0.42
PTGS2 P35354 1/20 0.42
SRC P12931 1/20 0.41
EGLN1 Q9GZT9 3/20 0.40
HTR2A P28223 1/20 0.40
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 2/20 0.39
USP2 O75604 1/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
TSHR P16473 1/20 0.39
CASP1 P29466 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7714381 0.99 MEN1 (0.49) MEN1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL7714708 0.96 LMNA (0.46) MEN1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL7716737 0.92 ALDH1A1 (0.48) MEN1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL7714147 0.91 ALDH1A1 (0.44) MEN1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL7712503 0.90 MEN1 (0.49) MEN1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL7708411 0.89 SRC (0.41) MEN1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL7716698 0.89 HTR1A (0.46) KMT2ALMNAHTR2AALDH1A1KDM4E
SCHEMBL7714501 0.86 LMNA (0.46) MEN1CYP3A4CYP2C9CYP2C19KMT2A
SCHEMBL7716722 0.85 HRH4 (0.51) CYP3A4KMT2AEGLN1ALDH1A1USP2
SCHEMBL7708442 0.84 LMNA (0.45) KMT2AROCK2ROCK1LMNALTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP disclosed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO disclosed